Researchers aim to improve chemotherapy by enhancing drug efficacy and reducing heart toxicity through dual activation of CAR and Nrf2 pathways.

Through the PATIENTS Going National Initiative, the program has built on its success of co-developing research with communities and advancing their work in the patient-centered research space by partnering with five new national community partners.

Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, of the School of Pharmacy is working to ensure drug delivery through the skin is safe and effective and just the right dose.

The University of Maryland, Baltimore (UMB) is building on its focus on innovative health care through a new partnership that will allow the university to advance its mission of improving the human condition.

New cohorts in PSC and PHSR arrive as the School launches curriculum updates and deepens its commitment to research and student success.

New students begin their PharmD journey with encouragement from leaders, opportunities for connection, and a shared sense of purpose.

Graduates poised to lead, innovate, and improve care for patients and families facing serious illness.

Celebrating big wins at AACP 2025, from top research awards to national leadership roles.

Honoring careers defined by compassionate clinical care, impactful teaching, and steadfast leadership.

The Gyi and Wagner Scholarships support student pharmacists interested in pharmapreneurship.

Natalie Eddington named honorary president; Katy Pincus joins Board of Trustees; Megan Chang awarded student scholarship.

Paul Shapiro, PhD, and Jeffrey Hasday, MD, are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases.